JOURNAL BACTERIOLOGY, July 1995, p. 4194–4197                                                                              Vol. 177,  14
0021-9193/95/$04.0010
Copyright 1995, American Society Microbiology



                 MurA (MurZ), Enzyme Catalyzes                   Committed Step Peptidoglycan Biosynthesis,
                         Essential Escherichia coli
          ERIC D. BROWN,1 EUGENIO  VIVAS,2 CHRISTOPHER T. WALSH,1                                 ROBERTO KOLTER2*
                                                                                         1
                Department Biological Chemistry Molecular Pharmacology Department Microbiology
                        Molecular Genetics,2 Harvard Medical School, Boston, Massachusetts 02115
                                            Received 1 February 1995/Accepted 4 1995

            Escherichia coli gene murZ recently shown encode UDP–N-acetylglucosamine enolpyruvyl trans-
         ferase, catalyzes committed step peptidoglycan biosynthesis (J. L. Marquardt, D.  Siegele,
         R. Kolter, C. T. Walsh, J. Bacteriol. 174:5748–5752, 1992). map position murZ (69.3 min) differed
         determined murA (90 min), gene previously proposed encode          activity (P. S. Venkateswaran H. C. Wu, J. Bacteriol. 110:935–944, 1972). construction
         chromosomal deletion murZ plasmid containing murZ arabinose control. Growth cells
         containing murZ deletion dependent expression murZ plasmid. conclude          murZ essential gene encodes sole UDP–N-acetylglucosamine enolpyruvyl transferase E. coli.          simplify nomenclature, recommend murA used designate gene 69.3 min encodes
         activity designation murZ abandoned.


   bacterial cell wall peptidoglycan essential cellular          tated chromosomal sequences cloned component involved maintenance shape protec-                 vector. plasmid carries temperature-sensitive origin tion osmotic shock lysis. Escherichia coli peptidogly-            replication (pSC101-ts) chloramphenicol resistance assembled basic building block composed                   nonpermissive temperature (428C) presence
N-acetylglucosamine (GlcNAc) N-acetylmuramic acid                      antibiotic, chromosomal integrants selected. attached pentapeptide (10). committed step            results generation tandem duplication wild-
peptidoglycan biosynthesis catalyzed UDP-GlcNAc enol-                type mutant alleles cloned gene plasmid
pyruvyl transferase. enzyme stems            sequence copies. subsequent shift unusual reaction mechanism (2) involving transfer enol-             permissive temperature (308C) selects excisants. 
pyruvate phosphoenolpyruvate 3-OH UDP-                      pending flanking sequence used recombina-
GlcNAc status target antibiotic                 tion event, excision results restoration wild-type
fosfomycin (6).                                                            gene creation mutant allele chromosome. Cells
   1972, Venkateswaran Wu reported isolation               lost plasmid selected temperature-sensitive fosfomycin-resistant mutant E.                presence pKO3 Bacillus subtilis sacB gene, coli (12, 14). UDP-GlcNAc enolpyruvyl transferase activ-               expression presence sucrose detrimental E. coli
ity mutant resistant fosfomycin vitro.               (1). Figure 1A depicts pKO3-DZ, contains kanamycin
antibiotic-resistant temperature-sensitive allele, desig-              resistance cassette murZ flanking sequences
nated murA, mapped conjugation near                       (denoted L R). kanamycin resistance gene makes
argECBH cluster 90 min (12, 14). recently cloned                  possible selection excision event generating mu-
E. coli gene encoding UDP-GlcNAc enolpyruvyl trans-
                                                                           tant allele following shift permissive temperature. ferase screening fosfomycin resistance resulting                                                                            result loss murZ recombination overexpression gene multicopy plasmid (9).
                                                                           cointegrant yield DmurZ::kan deletion-insertion muta- map position gene determined 69.3
min. map position differed murA,                  tion (Fig. 1C). designated gene murZ. Taken  studies                    attempts delete murZ, wild-type E. coli ZK126
suggested E. coli contain genes encoding                    transformed pKO3-DZ, transformants UDP-GlcNAc enolpyruvyl transferase activities. test                grown overnight 308C Luria-Bertani (LB) broth contain-
hypothesis, set construct null allele murZ.              ing kanamycin chloramphenicol  Table 1 strains
reasoned second gene encoded redundant trans-                  used study). estimated 10,000 transformants ferase, strain containing deletion murZ                   plated prewarmed LB agar plates containing chlor-
viable.                                                                    amphenicol kanamycin incubated 428C    strategy constructing precise deletion murZ                select cointegrants. Typically, 100 colonies ob-
employed gene replacement protocol originally developed               tained. Fifty colonies streaked LB agar
Hamilton et al. (5) refined recently Link et al. (7)           containing kanamycin 5  (wt/vol) sucrose incu- development knockout plasmid pKO3. Plasmid                 bated 308C 24 h select cells plasmid
pKO3 designed replace genomic DNA mu-                     excision resulted replacement murZ mutant
                                                                           allele loss plasmid.  isolates
                                                                           obtained way retained kanamycin chloramphen-
  * Corresponding author. Phone: (617) 432-1776. Fax: (617) 738-           icol resistance, indicating retention plasmid sequences. 7664. Electronic mail address: kolter@mbcrr.harvard.edu.                   retention chloramphenicol resistance growth su-

                                                                    4194
 VOL. 177, 1995                                                                                                                                NOTES          4195




                                                                                       FIG. 2. Verification gene replacement mutant ZK1745. PCR 
                                                                                    plifications purified plasmid DNA single-colony DNA primer                                                                                     (59-TAACCGCATTCATGCTGTGT-39), primer b (59-CACCCCTTGTATTA
                                                                                    CTGTTTATGT-39), primer c (59-ACAGAACGCAGTTGATGCGTAG
   FIG. 1. Strategy deletion chromosomal copy murZ.               CT-39) shown. Primers c  c) primers b c (b-c) used pKO3-DZ   constructed pKO3 (7), derived gene              amplifications templates: plasmid pJLM2 (containing replacement vectors developed originally Hamilton et al. (5). pKO3-DZ        murZ gene flanking DNA), colony ZK126 (wild-type E. coli), plasmid
tains kanamycin resistance cassette flanked sequence identical   pKO3-DZ (knockout vector containing kanamycin cassette murZ flank- 542 bp E. coli chromosome upstream adjacent start codon     ing sequences; legend Fig. 1), colony ZK1745 (E. coli mutant murZ (flank L) sequence identical 873 bp           ZK126 DmurZ::kn/pBAD30 .
immediately downstream termination codon murZ (flank R). flanking sequences amplified PCR Vent DNA polymerase template plasmid pJLM2 (8) following primers: upstream flank, 59-
CCTTAAGTAAACGACAAAGTGTA-39 (primer 1) 59-CGAGATCTCGC                            mid pBAD30 derived vector pBAD30, series
CCCCTTAGTTTGTTCTCAGT-39 (primer 2), downstream flank, 59-                       pBAD expression vectors recently 
GGGGCGAGATCTCGTAATCGTCTGAGAGCT-39 (primer 3) 59-CCT
TAAGAACAGTTAGGTAAAAA-39 (primer 4) (BglII sites underlined,                 structed aid studying phenotypes null mutations complementarity primers 2 3 shown italic). resulting PCR-      essential genes (4). Gene replacement experiments amplified flanks L R ligated complementary se-          ZK126/pBAD30 pKO3-DZ performed identically
quences   annealing (2 min 988C, 10 min 658C, 10 min 378C),       described  integration 428C LB (ii) extension Klenow polymerase 15 min 228C followed denaturation 10 min 758C, finally (iii) PCR amplification Vent      agar containing ampicillin, chloramphenicol, kanamycin, DNA polymerase primers 1 4. resulting L-R fragment (1,443 bp)           0.2  arabinose. Colonies 428C plates subse- blunt ligated EcoRV-digested pBluescript II SK create plasmid      quently streaked LB agar containing ampicillin, kanamycin,
pBlue-L R. kanamycin resistance cassette 1,706-bp BamHI fragment          5  sucrose, 0.2  arabinose incubated 308C. from mini-Tn10kan (13) ligated unique BglII site vector
pBlue-L R create pBlue-L Kn R. kanamycin resistance cassette             sucrose-containing plates, number isolates flanks digested plasmid pBlue-L Kn R (3,188-bp SalI-BamHI            chloramphenicol sensitive growth LB
fragment) ligated SalI-BamHI-digested plasmid pKO3 produce              agar containing kanamycin ampicillin dependent pKO3-DZ. Plasmid pBAD30 (B) contained murZ gene control             presence medium 0.2  arabinose col- arabinose promoter Pbad. murZ gene (sequence, 219 stop) amplified PCR Vent DNA polymerase (primers 59-GCGGCTAGCTA                   lected. Subsequent P1 transduction kanamycin resistance
ACTGAGAACAAACTAA-39 59-GCGCAAGCTTCGATTATTCGCCTT                                 mutants ZK126/pBAD30 TCAC-39) blunt ligated EcoRV-digested pBluescript SK generate           Ara mutant bearing plasmid (ZK1488/pBAD30 
plasmid pBlue  Subsequently, murZ gene digested pBlue              successful transductants plated 
(1,385-bp XbaI-KpnI fragment) ligated XbaI-KpnI-digested pBAD30
(C) (4).                                                                            dium containing 0.2  arabinose. Subsequent restreaking                                                                                     transductants LB minimal glycerol plates
                                                                                    yielded isolates presence 0.2  arabinose.
                                                                                     viability DmurZ::Kanr insertion-deletion mu-
crose easily explained spontaneous mutations                         tant maintained murZ provided sacB. results consistent hypothesis                     trans. murZ essential.                                                                Figure 2 illustrates use PCR confirm replace-
   test possibility murZ essential,                      ment murZ kanamycin resistance cassette experiment carried strain ZK126, car-                         mutant (ZK1745). Primers c complementary ried pBAD30 (Fig. 1B), plasmid containing murZ                            sequences flank murZ wild type (ZK126) control arabinose-inducible Pbad promoter. plas-                     location kanamycin cassette mutant ZK1745.
                                                                                    Amplification murZ-containing templates, plasmid
                                                                                    pJLM2 (containing cloned murZ flanking sequences)                         TABLE 1. Bacterial strains                                  ZK126 chromosome, produced fragments 1,488 bp,                                                                      Source                                                                                     expected intact murZ. Amplification  Strain                         Description                                         primers pKO3-DZ ZK1745 chromo-
                                                                     reference
                                                                                    failed generate amplified product  theoretical
ZK126             W3110 tna2 DlacU169                              3                product 1,848 bp). suspected difficulty ZK1488            ZK126 Dara                                       Lab stocks       amplifying product large inverted
ZK1745            ZK126 DmurZ::kan(pBAD30                        work
ZK1746            ZK1488 DmurZ::kan(pBAD30                       work
                                                                                    repeat 363 bp present 59 39
                                                                                    ends kanamycin resistance cassette. overcome  4196       NOTES                                                                                                                                   J. BACTERIOL.


                                                                                   growth wild-type ZK126 LB broth inoculation                                                                                    0.75 ml overnight culture diluted                                                                                    OD600 equivalent ZK1745 inoculum (OD600 5
                                                                                   0.05). lag phases growth wild type (2 h)
                                                                                   ZK1745 grown presence arabinose (4 h)
                                                                                   differed slightly, growth rates final optical densities                                                                                    dissimilar, indicating expression murZ Pbad
                                                                                   resulted slight growth differences compared                                                                                    growth wild-type control.  differences                                                                                    lag differences                                                                                    amounts viabilities inocula mutant                                                                                    wild-type cells.
   FIG. 3. Growth murZ deletion (ZK1745) presence absence
                                                                                       results provide strong evidence support arabinose. growth curves shown 100-ml shaking cultures ZK126     hypothesis murZ, located 69.3 min, essential gene LB (E), ZK1745 LB kanamycin, ampicillin, 0.2  arabinose (h),        question existence second ZK1745 LB kanamycin ampicillin arabinose ({).          UDP-GlcNAc enolpyruvyl transferase coded gene
Prior experiment, 2 ml LB kanamycin ampicillin arabinose inoculated cells single colony ZK1745  LB–
                                                                                   located near 90 min (murA) (12, 14). Consistent kanamycin–ampicillin–0.2  arabinose agarose plates), cells grew       conclusion inability candidate open reading
night OD600 0.05. growth curves ZK1745           frames second UDP-GlcNAc enolpyruvyl transferase arabinose (h {), 0.75 ml overnight culture inoculum.   using MurZ sequence probe search available case ZK126, overnight culture diluted OD600 0.05 0.75 ml diluted culture served inoculum.
                                                                                   translated sequences E. coli, include complete 80-
                   